CHEBI:231666 - GSK-256066

ChEBI IDCHEBI:231666
ChEBI NameGSK-256066
Stars
DefinitionGsk256066 has been used in trials studying the treatment and diagnostic of SAR, Asthma, Mild Asthma, Allergic Rhinitis, and Seasonal Allergic Rhinitis, among others.
Submitterruixy
DownloadsMolfile
FormulaC27H26N4O5S
Net Charge0
Average Mass518.595
Monoisotopic Mass518.16239
SMILESCOc1cccc(/N=c2/c(C(=N)O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)N(C)C)c4)cc23)c1
InChIInChI=1S/C27H26N4O5S/c1-16-11-21(37(34,35)20-10-5-7-17(12-20)27(33)31(2)3)14-22-24(16)29-15-23(26(28)32)25(22)30-18-8-6-9-19(13-18)36-4/h5-15H,1-4H3,(H2,28,32)(H,29,30)
InChIKeyJFHROPTYMMSOLG-UHFFFAOYSA-N
ChEBI Ontology
Outgoing Relation(s)
GSK-256066 (CHEBI:231666) is a organic molecular entity (CHEBI:50860)
Synonyms  Source
6-[3-(dimethylcarbamoyl)phenyl]sulfonyl-4-(3-methoxyanilino)-8-methylquinoline-3-carboxamideSUBMITTER
GSK256066SUBMITTER
Registry NumbersSources
CAS:801312-28-7SUBMITTER